SUN2 inhibitors are a class of chemical compounds that function by modulating the activity of the Sad1/UNC-84 domain-containing protein 2 (SUN2), which is an integral component of the linker of nucleoskeleton and cytoskeleton (LINC) complex. SUN2, along with other SUN domain proteins, is located within the inner nuclear membrane and interacts with nesprins, proteins that are anchored in the outer nuclear membrane, forming a bridge that connects the nucleus to the cytoskeleton. This connection is essential for various cellular processes such as nuclear positioning, mechanotransduction, and chromatin organization. Inhibiting SUN2 activity has been found to alter the structural and mechanical properties of the nucleus, affecting cellular responses to mechanical stimuli and potentially leading to changes in gene expression and nuclear integrity.
Chemically, SUN2 inhibitors often target the SUN domain of the protein, where its interaction with other LINC complex components occurs. These inhibitors are typically designed to disrupt the protein-protein interactions that are crucial for the LINC complex's functionality. By targeting the structural configuration of SUN2, these inhibitors can induce changes in the nuclear envelope's architecture, leading to alterations in nuclear migration and dynamics. Such inhibitors are valuable in studying the mechanical properties of the nucleus and understanding the roles of nuclear-cytoskeletal interactions in cellular processes such as migration, cell division, and differentiation. In addition, SUN2 inhibition provides insights into how disruptions in nuclear-cytoskeletal connectivity may contribute to broader cellular dysfunction, making them useful tools in molecular and cell biology research.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can downregulate SUN2 by binding to retinoic acid receptors that may repress the transcription of the SUN2 gene as part of retinoid-induced differentiation processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin may decrease SUN2 expression by inhibiting mTOR, which is crucial for cell cycle progression and growth, thereby possibly reducing the synthesis of nuclear envelope components including SUN2. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide can halt eukaryotic protein synthesis through ribosomal interference, leading to a broad reduction of protein levels including that of SUN2. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin can intercalate into DNA and break DNA strands by inhibiting topoisomerase II, which could lead to decreased transcription levels of genes such as SUN2. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C forms DNA crosslinks that inhibit DNA replication and transcription, potentially causing a substantial decrease in SUN2 protein synthesis due to blocked gene expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide can inhibit DNA topoisomerase II activity, leading to DNA damage and potentially attenuating the transcription of various genes, including the one encoding SUN2. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin, a topoisomerase I inhibitor, can initiate DNA damage that may lead to the repression of gene transcription, potentially diminishing the levels of SUN2. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can intercalate into DNA, disrupting the replication and transcription process, which may lead to a downregulation of genes including SUN2. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate can inhibit dihydrofolate reductase, thereby reducing nucleotide synthesis required for DNA replication, which could result in decreased transcription of SUN2. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA sequences, particularly those rich in guanine and cytosine, and can inhibit RNA polymerase movement, leading to a decrease in SUN2 mRNA synthesis. | ||||||